623
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects

, , , , &
Pages 921-928 | Received 09 Jan 2012, Accepted 03 Apr 2012, Published online: 01 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ruiqi Zhang & Ivan Fan-Ngai Hung. (2021) Approaches in broadening the neutralizing antibody response of the influenza vaccine. Expert Review of Vaccines 20:12, pages 1539-1547.
Read now
Timo Vesikari, Aino Forstén, Ashwani Arora, Theodore Tsai & Ralf Clemens. (2015) Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine. Human Vaccines & Immunotherapeutics 11:8, pages 2102-2112.
Read now
Brendon Y Chua, Lorena E Brown & David C Jackson. (2014) Considerations for the rapid deployment of vaccines against H7N9 influenza. Expert Review of Vaccines 13:11, pages 1327-1337.
Read now
Giuseppe Del Giudice, Elena Fragapane, Giovanni Della Cioppa & Rino Rappuoli. (2013) Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza. Expert Opinion on Biological Therapy 13:1, pages 121-135.
Read now

Articles from other publishers (12)

Dmitri Kazmin, Elizabeth A. Clutterbuck, Giorgio Napolitani, Amanda L. Wilkins, Andrea Tarlton, Amber J. Thompson, Emmanuele Montomoli, Guilia Lapini, Smiti Bihari, Rachel White, Claire Jones, Matthew D. Snape, Ushma Galal, Ly-Mee Yu, Rino Rappuoli, Giuseppe Del Giudice, Andrew J. Pollard & Bali Pulendran. (2023) Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children. npj Vaccines 8:1.
Crossref
Manish M. Patel, Lisa A. Grohskopf, Suryaprakash Sambhara, Jessica A. Belser, Jacqueline M. Katz & Alicia M. Fry. 2023. Plotkin's Vaccines. Plotkin's Vaccines 514 551.e31 .
James Peterson, Esther Van Twuijver, Eve Versage & Matthew Hohenboken. (2022) Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects. Vaccines 10:4, pages 497.
Crossref
Eve Versage, Esther van Twuijver, Wim Jansen, Ad Theeuwes, Daphne Sawlwin & Matthew Hohenboken. (2021) Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults. Vaccines 9:12, pages 1468.
Crossref
Zhuofan Li, Yiwen Zhao, Yibo Li & Xinyuan Chen. (2021) Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines 9:2, pages 75.
Crossref
Pornthep Chanthavanich, Edwin Anderson, Phirangkul Kerdpanich, Michael Bulitta, Niranjan Kanesa-thasan & Matthew Hohenboken. (2019) Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects. Pediatric Infectious Disease Journal 38:7, pages 757-764.
Crossref
Amanda L. Wilkins, Dmitri Kazmin, Giorgio Napolitani, Elizabeth A. Clutterbuck, Bali Pulendran, Claire-Anne Siegrist & Andrew J. Pollard. (2017) AS03- and MF59-Adjuvanted Influenza Vaccines in Children. Frontiers in Immunology 8.
Crossref
Kinnera E. Chada, Richard Forshee, Hana Golding, Steven Anderson & Hong Yang. (2017) A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines. Vaccine 35:24, pages 3162-3170.
Crossref
D. Kumar, V.H. Ferreira, P. Campbell, K. Hoschler & A. Humar. (2017) Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients. American Journal of Transplantation 17:1, pages 281-286.
Crossref
Gerald Aichinger, Barbara Grohmann-Izay, Maikel V. W. van der Velden, Sandor Fritsch, Manuela Koska, Daniel Portsmouth, Mary Kate Hart, Wael El-Amin, Otfried Kistner & P. Noel Barrett. (2015) Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults. Clinical and Vaccine Immunology 22:1, pages 46-55.
Crossref
M. V. W. van der Velden, R. Fritz, E. M. Pollabauer, D. Portsmouth, M. K. Howard, T. R. Kreil, T. Dvorak, S. Fritsch, T. Vesikari, J. Diez-Domingo, P. Richmond, B. W. Lee, O. Kistner, H. J. Ehrlich, P. N. Barrett & G. Aichinger. (2013) Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population. Journal of Infectious Diseases 209:1, pages 12-23.
Crossref
Giuseppe Del Giudice & Rino Rappuoli. 2015. Influenza Pathogenesis and Control - Volume II. Influenza Pathogenesis and Control - Volume II 151 180 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.